LIPO
LIPO clinical trials: LIPELLA PHARMACEUTICALS INC.
Every trial on ClinicalTrials.gov where LIPELLA PHARMACEUTICALS INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 3
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
LIPO on the catalyst calendar · LIPO registry changes
- Primary completion Jun 1, 2025Sponsor estimatePhase 2NCT06233591Evaluating LP-10 in Subjects With OLPLipella Pharmaceuticals, Inc. · Oral Lichen PlanusUnknown statusLIPOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 21, 2023ActualPhase 2NCT03129126The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic CystitisLipella Pharmaceuticals, Inc. · Hemorrhagic CystitisCompletedLIPOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 14, 2018ActualPhase 2NCT01393223Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder SyndromeLipella Pharmaceuticals, Inc. · Interstitial CystitisCompletedLIPOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 7, 2025ActualNo phase registeredNCT05811377Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging...Christopher J Chermansky, MD · IC - Interstitial CystitisCompletedLIPOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner